Literature DB >> 4128727

A new vasopressin analogue and fibrinolysis.

A M Gader, J da Costa, J D Cash.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4128727     DOI： 10.1016/s0140-6736(73)92805-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis.

Authors:  M I Jayson; C D Holland; A Keegan; K Illingworth; L Taylor
Journal:  Ann Rheum Dis       Date:  1991-01       Impact factor: 19.103

2.  Effects of lysine vasopressin and glypressin on the fibrinolytic system in cirrhosis.

Authors:  J G Douglas; J A Forrest; C V Prowse; J D Cash; N D Finlayson
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

Review 3.  The use of vasopressin in the treatment of upper gastrointestinal haemorrhage.

Authors:  D L Stump; T C Hardin
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

4.  Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.

Authors:  J E Kaufmann; A Oksche; C B Wollheim; G Günther; W Rosenthal; U M Vischer
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

5.  Pharmacokinetics and haematological effects of desmopressin.

Authors:  M Köhler; A Harris
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  A simple quantitative assay of vascular plasminogen activator--not only stimulated fibrinolytic activity but also basal fibrinolytic activity are correlated with venous fibrinolytic activity.

Authors:  S Y Hong; C S Lee
Journal:  Korean J Intern Med       Date:  1990-07       Impact factor: 2.884
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.